Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Brendan D. Manning, Ph.D.

Profile Picture
Other Positions

University of Massachusetts, Amherst, MassachusettsBS1993
Yale University, New Haven, ConnecticutPhD2000

Dr. Manning’s research is focused on the interface between signaling and metabolic control under physiological and pathophysiological conditions. He is particularly interested in defining the control mechanisms and functions of a complex signaling network that is implicated in a diverse array of human diseases, including the majority of genetic tumor syndromes and cancers, metabolic diseases such as diabetes and cardiovascular disease, neurocognitive and neurodegenerative diseases such as autism and Alzheimer’s, and autoimmune diseases. As a postdoctoral fellow in the laboratory of Lewis Cantley, he found that the tumor suppressor TSC2 is the key molecular link between the PI3K and mTOR pathways. This finding helped connect a primary growth factor and insulin-stimulated pathway (PI3K), which is also activated in the majority of cancers, to a ubiquitous nutrient-sensing protein kinase that promotes cell growth (mTOR). Since that early landmark discovery, he has continued to make major contributions to our understanding of this key regulatory hub in mammalian cells and tissues, including the recognition that mTOR is a central player in the control of anabolic processes driving the synthesis of proteins, nucleic acids, and lipids. His laboratory’s findings are providing both underlying mechanisms and potential therapeutic strategies for common complex diseases, such as cancer and diabetes. In the future, Dr. Manning plans to expand his research to explore molecular events contributing to aging and autism spectrum disorders, other areas where this signaling network has been implicated.

Dr. Manning received his PhD in molecular, cellular, and developmental biology from Yale University in 2000. After completing his postdoctoral training in signal transduction, cell biology, and systems biology at Harvard Medical School, he was recruited to the Harvard Chan School in 2004 as the first junior faculty member of the then newly established Department of Genetics and Complex Diseases (which changed its name to the Department of Molecular Metabolism in 2019). Dr. Manning is an affiliated faculty member in the Department of Cell Biology at Harvard Medical School and with the Dana Farber/Harvard Cancer Center.

Cell signaling and metabolism in cancer, metabolic diseases, and aging.

Research in the Manning Lab is delineating how signals from nutrients and growth factors are propagated to coordinately regulate nutrient metabolism, with implications in a wide variety of complex human diseases. Research efforts are focused in part on defining the regulatory mechanisms and functions of the PI3K-mTOR signaling network. This network senses and relays signals from nutrients and other growth cues to control key metabolic processes in cells and tissues. Importantly, frequent dysregulation of this network contributes to a diverse set of seemingly unrelated human diseases, including the majority of human cancers, genetic tumor syndromes (e.g, tuberous sclerosis complex, lymphangioleiomyomatosis, PTEN hamartoma tumor syndrome), metabolic diseases (e.g., obesity, type-2 diabetes, cardiovascular disease), autoimmune and inflammatory diseases (e.g., arthritis, lupus, hepatitis), and neuroglogical disorders (e.g., epilepsy, autism, Alzheimers). This signaling network also influences the lifespan of organisms and serves as a major connection between diet and the aging process. The Manning lab seeks to unravel the complex molecular regulation of the PI3K-mTOR network under both physiological and pathological states, and how its downstream functions contribute to metabolic homeostasis and dysfunction.

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R35CA197459 (MANNING, BRENDAN D.) Aug 14, 2015 - Jul 31, 2022
    Decoding and targeting the PI3K-mTOR signaling network in cancer
    Role: Principal Investigator
  2. R01CA181390 (MANNING, BRENDAN D.) Jul 1, 2014 - Jun 30, 2019
    Metabolic control of cell growth by the mTOR signaling network
    Role: Principal Investigator
  3. R01CA122617 (MANNING, BRENDAN D.) Jul 13, 2006 - Apr 30, 2016
    Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
    Role: Principal Investigator
  4. P01CA120964 (KWIATKOWSKI, DAVID J.) Apr 1, 2006 - Jul 31, 2023
    Molecular Pathogenesis of the Hamartoma Syndromes
    Role: Co-Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ristow M, Lee CH, De Bock K, Gladyshev VN, Hotamisligil GS, Manning BD. James R. Mitchell (1971-2020). Cell Metab. 2021 Mar 02; 33(3):458-461. PMID: 33657387.
    Citations:    Fields:    
  2. Torrence ME, MacArthur MR, Hosios AM, Valvezan AJ, Asara JM, Mitchell JR, Manning BD. The mTORC1-mediated activation of ATF4 promotes protein and glutathione synthesis downstream of growth signals. Elife. 2021 Mar 01; 10. PMID: 33646118.
    Citations:    Fields:    
  3. Valvezan AJ, McNamara MC, Miller SK, Torrence ME, Asara JM, Henske EP, Manning BD. IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex. JCI Insight. 2020 04 09; 5(7). PMID: 32271165.
    Citations: 1     Fields:    
  4. Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020 02; 20(2):74-88. PMID: 31686003.
    Citations: 104     Fields:    Translation:HumansAnimalsCells
  5. Brown FD, Sen DR, LaFleur MW, Godec J, Lukacs-Kornek V, Schildberg FA, Kim HJ, Yates KB, Ricoult SJH, Bi K, Trombley JD, Kapoor VN, Stanley IA, Cremasco V, Danial NN, Manning BD, Sharpe AH, Haining WN, Turley SJ. Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling. Nat Immunol. 2019 12; 20(12):1668-1680. PMID: 31636464.
    Citations: 7     Fields:    Translation:AnimalsCells
  6. Liu P, Gan W, Inuzuka H, Lazorchak AS, Gao D, Arojo O, Liu D, Wan L, Zhai B, Yu Y, Yuan M, Kim BM, Shaik S, Menon S, Gygi SP, Lee TH, Asara JM, Manning BD, Blenis J, Su B, Wei W. Author Correction: Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol. 2019 05; 21(5):662-663. PMID: 30783264.
    Citations: 1     Fields:    
  7. Hoxhaj G, Ben-Sahra I, Lockwood SE, Timson RC, Byles V, Henning GT, Gao P, Selfors LM, Asara JM, Manning BD. Direct stimulation of NADP+ synthesis through Akt-mediated phosphorylation of NAD kinase. Science. 2019 03 08; 363(6431):1088-1092. PMID: 30846598.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  8. Valvezan AJ, Manning BD. Molecular logic of mTORC1 signalling as a metabolic rheostat. Nat Metab. 2019 03; 1(3):321-333. PMID: 32694720.
    Citations: 12     Translation:HumansCells
  9. Manning BD. Signalling protein protects the heart muscle from pressure-related stress. Nature. 2019 02; 566(7743):187-188. PMID: 30737501.
    Citations: 1     Fields:    
  10. Yuan M, Kremer DM, Huang H, Breitkopf SB, Ben-Sahra I, Manning BD, Lyssiotis CA, Asara JM. Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC-MS/MS. Nat Protoc. 2019 02; 14(2):313-330. PMID: 30683937.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  11. Hosios AM, Manning BD. Lysosomal catch-and-release controls mTORC1. Nat Cell Biol. 2018 Sep; 20(9):996-997. PMID: 30154562.
    Citations:    Fields:    Translation:Cells
  12. Longchamp A, Mirabella T, Arduini A, MacArthur MR, Das A, Treviño-Villarreal JH, Hine C, Ben-Sahra I, Knudsen NH, Brace LE, Reynolds J, Mejia P, Tao M, Sharma G, Wang R, Corpataux JM, Haefliger JA, Ahn KH, Lee CH, Manning BD, Sinclair DA, Chen CS, Ozaki CK, Mitchell JR. Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S Production. Cell. 2018 03 22; 173(1):117-129.e14. PMID: 29570992.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  13. Zabala-Letona A, Arruabarrena-Aristorena A, Martín-Martín N, Fernandez-Ruiz S, Sutherland JD, Clasquin M, Tomas-Cortazar J, Jimenez J, Torres I, Quang P, Ximenez-Embun P, Bago R, Ugalde-Olano A, Loizaga-Iriarte A, Lacasa-Viscasillas I, Unda M, Torrano V, Cabrera D, van Liempd SM, Cendon Y, Castro E, Murray S, Revandkar A, Alimonti A, Zhang Y, Barnett A, Lein G, Pirman D, Cortazar AR, Arreal L, Prudkin L, Astobiza I, Valcarcel-Jimenez L, Zuñiga-García P, Fernandez-Dominguez I, Piva M, Caro-Maldonado A, Sánchez-Mosquera P, Castillo-Martín M, Serra V, Beraza N, Gentilella A, Thomas G, Azkargorta M, Elortza F, Farràs R, Olmos D, Efeyan A, Anguita J, Muñoz J, Falcón-Pérez JM, Barrio R, Macarulla T, Mato JM, Martinez-Chantar ML, Cordon-Cardo C, Aransay AM, Marks K, Baselga J, Tabernero J, Nuciforo P, Manning BD, Marjon K, Carracedo A. Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer. Nature. 2018 02 22; 554(7693):554. PMID: 29342137.
    Citations:    Fields:    
  14. Housden BE, Li Z, Kelley C, Wang Y, Hu Y, Valvezan AJ, Manning BD, Perrimon N. Improved detection of synthetic lethal interactions in Drosophila cells using variable dose analysis (VDA). Proc Natl Acad Sci U S A. 2017 12 12; 114(50):E10755-E10762. PMID: 29183982.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  15. Kelsey I, Zbinden M, Byles V, Torrence M, Manning BD. mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci. Sci Rep. 2017 11 23; 7(1):16112. PMID: 29170467.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  16. Hoxhaj G, Hughes-Hallett J, Timson RC, Ilagan E, Yuan M, Asara JM, Ben-Sahra I, Manning BD. The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels. Cell Rep. 2017 Oct 31; 21(5):1331-1346. PMID: 29091770.
    Citations: 37     Fields:    Translation:HumansAnimalsCells
  17. Valvezan AJ, Turner M, Belaid A, Lam HC, Miller SK, McNamara MC, Baglini C, Housden BE, Perrimon N, Kwiatkowski DJ, Asara JM, Henske EP, Manning BD. mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability. Cancer Cell. 2017 11 13; 32(5):624-638.e5. PMID: 29056426.
    Citations: 36     Fields:    Translation:HumansAnimalsCells
  18. Manning BD. Game of TOR - The Target of Rapamycin Rules Four Kingdoms. N Engl J Med. 2017 Sep 28; 377(13):1297-9. PMID: 28874074.
    Citations: 4     Fields:    Translation:AnimalsCells
  19. Heintz C, Doktor TK, Lanjuin A, Escoubas CC, Zhang Y, Weir HJ, Dutta S, Silva-García CG, Bruun GH, Morantte I, Hoxhaj G, Manning BD, Andresen BS, Mair WB. Corrigendum: Splicing factor 1 modulates dietary restriction and TORC1 pathway longevity in C. elegans. Nature. 2017 07 27; 547(7664):476. PMID: 28700577.
    Citations: 3     Fields:    
  20. Zabala-Letona A, Arruabarrena-Aristorena A, Martín-Martín N, Fernandez-Ruiz S, Sutherland JD, Clasquin M, Tomas-Cortazar J, Jimenez J, Torres I, Quang P, Ximenez-Embun P, Bago R, Ugalde-Olano A, Loizaga-Iriarte A, Lacasa-Viscasillas I, Unda M, Torrano V, Cabrera D, van Liempd SM, Cendon Y, Castro E, Murray S, Revandkar A, Alimonti A, Zhang Y, Barnett A, Lein G, Pirman D, Cortazar AR, Arreal L, Prudkin L, Astobiza I, Valcarcel-Jimenez L, Zuñiga-García P, Fernandez-Dominguez I, Piva M, Caro-Maldonado A, Sánchez-Mosquera P, Castillo-Martín M, Serra V, Beraza N, Gentilella A, Thomas G, Azkargorta M, Elortza F, Farràs R, Olmos D, Efeyan A, Anguita J, Muñoz J, Falcón-Pérez JM, Barrio R, Macarulla T, Mato JM, Martinez-Chantar ML, Cordon-Cardo C, Aransay AM, Marks K, Baselga J, Tabernero J, Nuciforo P, Manning BD, Marjon K, Carracedo A. mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer. Nature. 2017 07 06; 547(7661):109-113. PMID: 28658205.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  21. Manning BD, Toker A. AKT/PKB Signaling: Navigating the Network. Cell. 2017 04 20; 169(3):381-405. PMID: 28431241.
    Citations: 619     Fields:    Translation:HumansAnimalsCells
  22. Ben-Sahra I, Manning BD. mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol. 2017 04; 45:72-82. PMID: 28411448.
    Citations: 125     Fields:    Translation:HumansAnimalsCells
  23. Breitkopf SB, Ricoult SJH, Yuan M, Xu Y, Peake DA, Manning BD, Asara JM. A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC-MS/MS from any biological source. Metabolomics. 2017 Mar; 13(3). PMID: 28496395.
    Citations: 25     Fields:    
  24. Howell JJ, Hellberg K, Turner M, Talbott G, Kolar MJ, Ross DS, Hoxhaj G, Saghatelian A, Shaw RJ, Manning BD. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex. Cell Metab. 2017 02 07; 25(2):463-471. PMID: 28089566.
    Citations: 86     Fields:    Translation:HumansAnimalsCells
  25. Heintz C, Doktor TK, Lanjuin A, Escoubas C, Zhang Y, Weir HJ, Dutta S, Silva-García CG, Bruun GH, Morantte I, Hoxhaj G, Manning BD, Andresen BS, Mair WB. Splicing factor 1 modulates dietary restriction and TORC1 pathway longevity in C. elegans. Nature. 2017 01 05; 541(7635):102-106. PMID: 27919065.
    Citations: 38     Fields:    Translation:AnimalsCells
  26. Ricoult SJ, Dibble CC, Asara JM, Manning BD. Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1. Mol Cell Biol. 2016 09 15; 36(18):2384-95. PMID: 27354064.
    Citations: 10     Fields:    Translation:HumansCells
  27. Ilagan E, Manning BD. Emerging role of mTOR in the response to cancer therapeutics. Trends Cancer. 2016 May; 2(5):241-251. PMID: 27668290.
    Citations: 38     Fields:    
  28. Sahin M, Henske EP, Manning BD, Ess KC, Bissler JJ, Klann E, Kwiatkowski DJ, Roberds SL, Silva AJ, Hillaire-Clarke CS, Young LR, Zervas M, Mamounas LA. Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference. Pediatr Neurol. 2016 07; 60:1-12. PMID: 27267556.
    Citations: 19     Fields:    Translation:HumansAnimals
  29. Hallett JEH, Manning BD. CASTORing New Light on Amino Acid Sensing. Cell. 2016 Mar 24; 165(1):15-17. PMID: 27015302.
    Citations: 6     Fields:    Translation:Cells
  30. Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, Wang J, Ben-Sahra I, Byles V, Polynne-Stapornkul T, Espinosa EC, Lamming D, Manning BD, Zhang Y, Blair IA, Horng T. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife. 2016 Feb 19; 5. PMID: 26894960.
    Citations: 93     Fields:    Translation:AnimalsCells
  31. Ben-Sahra I, Hoxhaj G, Ricoult SJH, Asara JM, Manning BD. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science. 2016 Feb 12; 351(6274):728-733. PMID: 26912861.
    Citations: 203     Fields:    Translation:HumansAnimalsCells
  32. Zhang Y, Manning BD. Zhang & Manning reply. Nature. 2016 Jan 21; 529(7586):E2-3. PMID: 26791732.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  33. Housden BE, Valvezan AJ, Kelley C, Sopko R, Hu Y, Roesel C, Lin S, Buckner M, Tao R, Yilmazel B, Mohr SE, Manning BD, Perrimon N. Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi. Sci Signal. 2015 Sep 08; 8(393):rs9. PMID: 26350902.
    Citations: 57     Fields:    Translation:HumansAnimalsCells
  34. Priolo C, Ricoult SJ, Khabibullin D, Filippakis H, Yu J, Manning BD, Clish C, Henske EP. Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis. Am J Respir Cell Mol Biol. 2015 Jul; 53(1):33-41. PMID: 25780943.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  35. Ricoult SJ, Yecies JL, Ben-Sahra I, Manning BD. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP. Oncogene. 2016 Mar 10; 35(10):1250-60. PMID: 26028026.
    Citations: 63     Fields:    Translation:HumansAnimalsCells
  36. Zhang Y, Manning BD. mTORC1 signaling activates NRF1 to increase cellular proteasome levels. . 2015; 14(13):2011-7. PMID: 26017155.
    Citations: 23     Translation:HumansAnimalsCells
  37. Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, Triantafellow E, Menon S, Wang Z, Honda A, Pardee G, Cantwell J, Luu C, Cornella-Taracido I, Harrington E, Fekkes P, Lei H, Fang Q, Digan ME, Burdick D, Powers AF, Helliwell SB, D'Aquin S, Bastien J, Wang H, Wiederschain D, Kuerth J, Bergman P, Schwalb D, Thomas J, Ugwonali S, Harbinski F, Tallarico J, Wilson CJ, Myer VE, Porter JA, Bussiere DE, Finan PM, Labow MA, Mao X, Hamann LG, Manning BD, Valdez RA, Nicholson T, Schirle M, Knapp MS, Keaney EP, Murphy LO. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol. 2014 Nov; 16(11):1069-79. PMID: 25327288.
    Citations: 180     Fields:    Translation:HumansAnimalsCells
  38. Liu XS, Haines JE, Mehanna EK, Genet MD, Ben-Sahra I, Asara JM, Manning BD, Yuan ZM. ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis. Genes Dev. 2014 Sep 01; 28(17):1917-28. PMID: 25184678.
    Citations: 30     Fields:    Translation:HumansAnimalsCells
  39. Kwiatkowski DJ, Manning BD. Molecular basis of giant cells in tuberous sclerosis complex. N Engl J Med. 2014 Aug 21; 371(8):778-80. PMID: 25140966.
    Citations: 18     Fields:    Translation:HumansCells
  40. Harputlugil E, Hine C, Vargas D, Robertson L, Manning BD, Mitchell JR. The TSC complex is required for the benefits of dietary protein restriction on stress resistance in vivo. Cell Rep. 2014 Aug 21; 8(4):1160-70. PMID: 25131199.
    Citations: 28     Fields:    Translation:AnimalsCells
  41. Zhang Y, Nicholatos J, Dreier JR, Ricoult SJ, Widenmaier SB, Hotamisligil GS, Kwiatkowski DJ, Manning BD. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature. 2014 Sep 18; 513(7518):440-3. PMID: 25043031.
    Citations: 112     Fields:    Translation:HumansAnimalsCells
  42. Lall R, Ganapathy S, Yang M, Xiao S, Xu T, Su H, Shadfan M, Asara JM, Ha CS, Ben-Sahra I, Manning BD, Little JB, Yuan ZM. Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response. Cell Death Differ. 2014 May; 21(5):836-44. PMID: 24583639.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  43. Menon S, Dibble CC, Talbott G, Hoxhaj G, Valvezan AJ, Takahashi H, Cantley LC, Manning BD. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell. 2014 Feb 13; 156(4):771-85. PMID: 24529379.
    Citations: 279     Fields:    Translation:HumansAnimalsCells
  44. Liu P, Gan W, Inuzuka H, Lazorchak AS, Gao D, Arojo O, Liu D, Wan L, Zhai B, Yu Y, Yuan M, Kim BM, Shaik S, Menon S, Gygi SP, Lee TH, Asara JM, Manning BD, Blenis J, Su B, Wei W. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol. 2013 Nov; 15(11):1340-50. PMID: 24161930.
    Citations: 116     Fields:    Translation:HumansCells
  45. Kelsey I, Manning BD. mTORC1 status dictates tumor response to targeted therapeutics. Sci Signal. 2013 Sep 24; 6(294):pe31. PMID: 24065143.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  46. Howell JJ, Ricoult SJ, Ben-Sahra I, Manning BD. A growing role for mTOR in promoting anabolic metabolism. Biochem Soc Trans. 2013 Aug; 41(4):906-12. PMID: 23863154.
    Citations: 88     Fields:    Translation:HumansCells
  47. Ersoy BA, Tarun A, D'Aquino K, Hancer NJ, Ukomadu C, White MF, Michel T, Manning BD, Cohen DE. Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling. Sci Signal. 2013 Jul 30; 6(286):ra64. PMID: 23901139.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  48. Menon S, Manning BD. Cell signalling: nutrient sensing lost in cancer. Nature. 2013 Jun 27; 498(7455):444-5. PMID: 23803840.
    Citations: 6     Fields:    Translation:HumansCells
  49. Manning BD. Adaptation to starvation: translating a matter of life or death. Cancer Cell. 2013 Jun 10; 23(6):713-5. PMID: 23763997.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  50. Dibble CC, Manning BD. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol. 2013 Jun; 15(6):555-64. PMID: 23728461.
    Citations: 280     Fields:    Translation:HumansAnimalsCells
  51. Liu Y, Marks K, Cowley GS, Carretero J, Liu Q, Nieland TJ, Xu C, Cohoon TJ, Gao P, Zhang Y, Chen Z, Altabef AB, Tchaicha JH, Wang X, Choe S, Driggers EM, Zhang J, Bailey ST, Sharpless NE, Hayes DN, Patel NM, Janne PA, Bardeesy N, Engelman JA, Manning BD, Shaw RJ, Asara JM, Scully R, Kimmelman A, Byers LA, Gibbons DL, Wistuba II, Heymach JV, Kwiatkowski DJ, Kim WY, Kung AL, Gray NS, Root DE, Cantley LC, Wong KK. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discov. 2013 Aug; 3(8):870-9. PMID: 23715154.
    Citations: 62     Fields:    Translation:HumansAnimalsCells
  52. Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science. 2013 Mar 15; 339(6125):1323-8. PMID: 23429703.
    Citations: 238     Fields:    Translation:HumansAnimalsCells
  53. Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun. 2013; 4:2834. PMID: 24280772.
    Citations: 145     Fields:    Translation:AnimalsCells
  54. Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, Finan PM, Kwiatkowski DJ, Murphy LO, Manning BD. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell. 2012 Aug 24; 47(4):535-46. PMID: 22795129.
    Citations: 225     Fields:    Translation:HumansCells
  55. Manning BD. Comment on "A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation": building a model of the mTOR signaling network with a potentially faulty tool. Sci Signal. 2012 Jul 10; 5(232):lc3; author reply lc4. PMID: 22786721.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  56. Menon S, Yecies JL, Zhang HH, Howell JJ, Nicholatos J, Harputlugil E, Bronson RT, Kwiatkowski DJ, Manning BD. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal. 2012 Mar 27; 5(217):ra24. PMID: 22457330.
    Citations: 73     Fields:    Translation:AnimalsCells
  57. Auricchio N, Malinowska I, Shaw R, Manning BD, Kwiatkowski DJ. Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC). PLoS One. 2012; 7(2):e31900. PMID: 22363765.
    Citations: 15     Fields:    Translation:HumansAnimals
  58. Ricoult SJ, Manning BD. The multifaceted role of mTORC1 in the control of lipid metabolism. . 2013 Mar 01; 14(3):242-51. PMID: 23399656.
    Citations: 78     Translation:HumansAnimalsCells
  59. Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, Gini B, Dang J, Zhu S, Yang H, De Jesus J, Amzajerdi AN, Zhang Y, Dibble CC, Dan H, Rinkenbaugh A, Yong WH, Vinters HV, Gera JF, Cavenee WK, Cloughesy TF, Manning BD, Baldwin AS, Mischel PS. Oncogenic EGFR signaling activates an mTORC2-NF-?B pathway that promotes chemotherapy resistance. Cancer Discov. 2011 Nov; 1(6):524-38. PMID: 22145100.
    Citations: 128     Fields:    Translation:HumansCells
  60. De Raedt T, Walton Z, Yecies JL, Li D, Chen Y, Malone CF, Maertens O, Jeong SM, Bronson RT, Lebleu V, Kalluri R, Normant E, Haigis MC, Manning BD, Wong KK, Macleod KF, Cichowski K. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell. 2011 Sep 13; 20(3):400-13. PMID: 21907929.
    Citations: 114     Fields:    Translation:AnimalsCells
  61. Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, Gorgun C, Kwiatkowski DJ, Hotamisligil GS, Lee CH, Manning BD. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 2011 Jul 06; 14(1):21-32. PMID: 21723501.
    Citations: 209     Fields:    Translation:AnimalsCells
  62. Yecies JL, Manning BD. Transcriptional control of cellular metabolism by mTOR signaling. Cancer Res. 2011 Apr 15; 71(8):2815-20. PMID: 21487041.
    Citations: 66     Fields:    Translation:HumansAnimalsCells
  63. Yecies JL, Manning BD. mTOR links oncogenic signaling to tumor cell metabolism. J Mol Med (Berl). 2011 Mar; 89(3):221-8. PMID: 21301797.
    Citations: 79     Fields:    Translation:HumansCells
  64. Howell JJ, Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab. 2011 Mar; 22(3):94-102. PMID: 21269838.
    Citations: 147     Fields:    Translation:HumansAnimalsCells
  65. Manning BD. Insulin signaling: inositol phosphates get into the Akt. Cell. 2010 Dec 10; 143(6):861-3. PMID: 21145450.
    Citations: 9     Fields:    
  66. Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB, Murphy LO, Manning BD. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell. 2010 Jul 30; 39(2):171-83. PMID: 20670887.
    Citations: 710     Fields:    Translation:HumansAnimalsCells
  67. Yecies JL, Manning BD. Chewing the fat on tumor cell metabolism. Cell. 2010 Jan 08; 140(1):28-30. PMID: 20085702.
    Citations: 12     Fields:    Translation:Humans
  68. Dibble CC, Manning BD. A molecular link between AKT regulation and chemotherapeutic response. Cancer Cell. 2009 Sep 08; 16(3):178-80. PMID: 19732717.
    Citations: 11     Fields:    Translation:HumansCells
  69. Dibble CC, Asara JM, Manning BD. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol Cell Biol. 2009 Nov; 29(21):5657-70. PMID: 19720745.
    Citations: 206     Fields:    Translation:HumansAnimalsCells
  70. Huang J, Wu S, Wu CL, Manning BD. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res. 2009 Aug 01; 69(15):6107-14. PMID: 19602587.
    Citations: 53     Fields:    Translation:HumansAnimalsCells
  71. Zhang HH, Huang J, Düvel K, Boback B, Wu S, Squillace RM, Wu CL, Manning BD. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One. 2009 Jul 10; 4(7):e6189. PMID: 19593385.
    Citations: 142     Fields:    Translation:HumansAnimalsCells
  72. James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, Gusella JF, Ramesh V. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol. 2009 Aug; 29(15):4250-61. PMID: 19451225.
    Citations: 103     Fields:    Translation:HumansAnimalsCells
  73. Manning BD. Challenges and opportunities in defining the essential cancer kinome. Sci Signal. 2009 Mar 24; 2(63):pe15. PMID: 19318621.
    Citations: 17     Fields:    Translation:HumansCells
  74. Huang J, Manning BD. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans. 2009 Feb; 37(Pt 1):217-22. PMID: 19143635.
    Citations: 290     Fields:    Translation:HumansAnimals
  75. Menon S, Manning BD. Common corruption of the mTOR signaling network in human tumors. Oncogene. 2008 Dec; 27 Suppl 2:S43-51. PMID: 19956179.
    Citations: 134     Fields:    Translation:HumansAnimalsCells
  76. Chakrabarti P, Anno T, Manning BD, Luo Z, Kandror KV. The mammalian target of rapamycin complex 1 regulates leptin biosynthesis in adipocytes at the level of translation: the role of the 5'-untranslated region in the expression of leptin messenger ribonucleic acid. Mol Endocrinol. 2008 Oct; 22(10):2260-7. PMID: 18653778.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  77. Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008 Jun 01; 412(2):179-90. PMID: 18466115.
    Citations: 463     Fields:    Translation:HumansAnimalsCells
  78. Huang J, Dibble CC, Matsuzaki M, Manning BD. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol. 2008 Jun; 28(12):4104-15. PMID: 18411301.
    Citations: 218     Fields:    Translation:HumansAnimalsCells
  79. Ozcan U, Ozcan L, Yilmaz E, Düvel K, Sahin M, Manning BD, Hotamisligil GS. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell. 2008 Mar 14; 29(5):541-51. PMID: 18342602.
    Citations: 211     Fields:    Translation:HumansAnimalsCells
  80. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 2007 Jun 29; 129(7):1261-74. PMID: 17604717.
    Citations: 2287     Fields:    Translation:Cells
  81. Zhang HH, Lipovsky AI, Dibble CC, Sahin M, Manning BD. S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell. 2006 Oct 20; 24(2):185-97. PMID: 17052453.
    Citations: 136     Fields:    Translation:HumansAnimalsCells
  82. Prichard R, Butt J, Al-Sariff N, Frohlich S, Murphy S, Manning B, Ravi N, Reynolds JV. Management of spontaneous rupture of the oesophagus (Boerhaave's syndrome): single centre experience of 18 cases. Ir J Med Sci. 2006 Oct-Dec; 175(4):66-70. PMID: 17312833.
    Citations: 2     Fields:    Translation:Humans
  83. Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA, Sawai ET, Molinolo A, Gutkind JS, Montaner S. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell. 2006 Aug; 10(2):133-43. PMID: 16904612.
    Citations: 86     Fields:    Translation:HumansAnimalsCells
  84. Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet. 2005 Oct 15; 14 Spec No. 2:R251-8. PMID: 16244323.
    Citations: 170     Fields:    Translation:Cells
  85. Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev. 2005 Aug 01; 19(15):1773-8. PMID: 16027169.
    Citations: 115     Fields:    Translation:HumansAnimalsCells
  86. Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, Witters LA, Ellisen LW, Kaelin WG. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004 Dec 01; 18(23):2893-904. PMID: 15545625.
    Citations: 500     Fields:    Translation:AnimalsCells
  87. Manning BD. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol. 2004 Nov 08; 167(3):399-403. PMID: 15533996.
    Citations: 204     Fields:    Translation:HumansCells
  88. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, Cantley LC. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell. 2004 Jul; 6(1):91-9. PMID: 15261145.
    Citations: 384     Fields:    Translation:AnimalsCells
  89. Manning BD, Cantley LC. Rheb fills a GAP between TSC and TOR. Trends Biochem Sci. 2003 Nov; 28(11):573-6. PMID: 14607085.
    Citations: 158     Fields:    Translation:HumansCells
  90. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell. 2003 Oct; 4(4):257-62. PMID: 14585353.
    Citations: 431     Fields:    Translation:HumansAnimalsCells
  91. Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol. 2003 Aug 05; 13(15):1259-68. PMID: 12906785.
    Citations: 448     Fields:    Translation:HumansCells
  92. Manning BD, Cantley LC. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem Soc Trans. 2003 Jun; 31(Pt 3):573-8. PMID: 12773158.
    Citations: 73     Fields:    Translation:HumansCells
  93. Manning BD, Cantley LC. Hitting the target: emerging technologies in the search for kinase substrates. Sci STKE. 2002 Dec 10; 2002(162):pe49. PMID: 12475999.
    Citations: 47     Fields:    Translation:HumansAnimals
  94. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A. 2002 Oct 15; 99(21):13571-6. PMID: 12271141.
    Citations: 274     Fields:    Translation:HumansCells
  95. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell. 2002 Jul; 10(1):151-62. PMID: 12150915.
    Citations: 580     Fields:    Translation:HumansAnimalsCells
  96. Manning BD, Snyder M. Drivers and passengers wanted! the role of kinesin-associated proteins. Trends Cell Biol. 2000 Jul; 10(7):281-9. PMID: 10856931.
    Citations: 20     Fields:    Translation:Animals
  97. Barrett JG, Manning BD, Snyder M. The Kar3p kinesin-related protein forms a novel heterodimeric structure with its associated protein Cik1p. Mol Biol Cell. 2000 Jul; 11(7):2373-85. PMID: 10888675.
    Citations: 29     Fields:    Translation:AnimalsCells
  98. Manning BD, Barrett JG, Wallace JA, Granok H, Snyder M. Differential regulation of the Kar3p kinesin-related protein by two associated proteins, Cik1p and Vik1p. J Cell Biol. 1999 Mar 22; 144(6):1219-33. PMID: 10087265.
    Citations: 55     Fields:    Translation:AnimalsCells
  99. Manning BD, Padmanabha R, Snyder M. The Rho-GEF Rom2p localizes to sites of polarized cell growth and participates in cytoskeletal functions in Saccharomyces cerevisiae. Mol Biol Cell. 1997 Oct; 8(10):1829-44. PMID: 9348527.
    Citations: 40     Fields:    Translation:AnimalsCells
  100. Lessie TG, Hendrickson W, Manning BD, Devereux R. Genomic complexity and plasticity of Burkholderia cepacia. FEMS Microbiol Lett. 1996 Nov 01; 144(2-3):117-28. PMID: 8900054.
    Citations: 54     Fields:    Translation:CellsPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Manning's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (417)
Co-Authors (55)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.